SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,021,000 | +66.6% | 180,436 | +63.7% | 0.00% | +100.0% |
| Q2 2017 | $1,213,000 | +25.2% | 110,239 | +11.5% | 0.00% | 0.0% |
| Q1 2017 | $969,000 | -16.6% | 98,884 | -8.1% | 0.00% | -50.0% |
| Q4 2016 | $1,162,000 | +13.5% | 107,612 | +7.7% | 0.00% | 0.0% |
| Q3 2016 | $1,024,000 | -36.9% | 99,917 | -19.6% | 0.00% | -33.3% |
| Q2 2016 | $1,623,000 | -30.8% | 124,268 | -41.7% | 0.00% | -25.0% |
| Q1 2016 | $2,344,000 | +152.6% | 213,074 | +111.3% | 0.00% | +100.0% |
| Q4 2015 | $928,000 | +13.0% | 100,859 | -14.7% | 0.00% | 0.0% |
| Q3 2015 | $821,000 | -24.9% | 118,265 | +6.3% | 0.00% | 0.0% |
| Q2 2015 | $1,093,000 | +0.7% | 111,254 | -9.1% | 0.00% | 0.0% |
| Q1 2015 | $1,085,000 | +15.3% | 122,447 | +14.0% | 0.00% | 0.0% |
| Q4 2014 | $941,000 | +35.2% | 107,443 | +6.3% | 0.00% | 0.0% |
| Q3 2014 | $696,000 | +219.3% | 101,035 | +144.0% | 0.00% | – |
| Q2 2014 | $218,000 | +240.6% | 41,400 | +193.6% | 0.00% | – |
| Q1 2014 | $64,000 | -69.4% | 14,103 | -66.1% | 0.00% | -100.0% |
| Q4 2013 | $209,000 | -7.1% | 41,553 | -6.3% | 0.00% | 0.0% |
| Q3 2013 | $225,000 | +22.3% | 44,326 | +19.3% | 0.00% | 0.0% |
| Q2 2013 | $184,000 | – | 37,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|